Genesys Capital (“Genesys”) is pleased to announce the upcoming closing of Genesys Ventures IV LP (“Fund IV” or the “fund”) to continue its successful track record of building Canadian life science ...
Beneficient announces $1.91 million financing for Mendoza Ventures Growth Fund III, enhancing its GP Primary Commitment Program. Beneficient, a technology-enabled platform providing capital solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback